![Andrew Hindman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Andrew Asa Hindman is currently a Director at Biotie Therapies Oy.
He was previously the President & Chief Executive Officer at Tobira Therapeutics, Inc. and Senior Vice President-Corporate Development at Gilead Sciences, Inc. He also held the position of Vice President-Corporate Development at Onyx Pharmaceuticals, Inc. and Chief Business Officer at Acorda Therapeutics, Inc. Additionally, he was the Senior Vice President-Corporate Development at Nodality, Inc. Mr. Hindman has an MBA from The Trustees of Columbia University in The City of New York and an MBA from Haas School of Business.
He also has an undergraduate degree from Wesleyan University.
Currently, he is the Chief Financial Officer & Senior Vice President at Theravance Biopharma, Inc.
Antiguos cargos conocidos de Andrew Hindman.
| Empresas | Cargo | Fin |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Director Financiero/CFO | 31/12/2022 |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | 31/05/2019 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Director Ejecutivo | 01/01/2014 |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Corporate Officer/Principal | 01/01/2011 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2008 |
Formación de Andrew Hindman.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
80
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Hindman
